Susquehanna International Group, LLP Sangamo Therapeutics, Inc Transaction History
Susquehanna International Group, LLP
- $823 Billion
- Q3 2025
A detailed history of Susquehanna International Group, LLP transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 2,420,366 shares of SGMO stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,420,366
Previous 773,266
213.01%
Holding current value
$1.06 Million
Previous $417,000
288.73%
% of portfolio
0.0%
Previous 0.0%
Shares
34 transactions
Others Institutions Holding SGMO
# of Institutions
124Shares Held
62.5MCall Options Held
953KPut Options Held
1.11M-
Vanguard Group Inc Valley Forge, PA11.6MShares$5.11 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny10.2MShares$4.48 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.07 Million0.0% of portfolio
-
Gsa Capital Partners LLP London, X03.66MShares$1.61 Million0.21% of portfolio
-
Geode Capital Management, LLC Boston, MA3.29MShares$1.45 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $68.9M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...